Deadlines and Other Important Dates
Registration Deadline: Friday, April 6, 2018, 12:00 PM Eastern Time – REQUIRED
- Applicants will receive portal user name/password, URL to start their LOI, LOI instructions and templates within one business day following registration.
- Note that the amfAR office will be closed on Friday, December 22, 2017; Monday, December 25, 2017; Friday, December 29, 2017; Monday, January 1, 2018; Monday, January 15, 2018; and Monday, February 19, 2018. Materials will be sent on the first business day following those closures.
LOI Submission Deadline: Wednesday, April 11, 2018, 3PM Eastern Time (no extensions will be granted)
Application Invitation: Late May, 2018 (TENTATIVE)
Application Submission: Early August, 2018 (TENTATIVE)
Notice of Decision: Late September, 2018 (TENTATIVE)
Performance Period Start: October 1, 2018
Submission, Review and Approval Pipeline
- Interested applicants must register online to obtain portal link, username/password and complete information about Letter of Intent requirements.
Click here to register. - LOIs are submitted online.
- LOIs are reviewed by amfAR staff to ensure that (a) eligibility requirements are met; (b) proposed research is responsive to the RFP and in line with amfAR objectives.
LOIs that meet those criteria proceed to peer review. - LOIs are reviewed by leading HIV experts and scored on the following criteria:
- Expected impact on HIV cure clinical research
- Appropriateness of the proposed work with respect to available funds
- Competency and track record of members of the team
- Applicants with the highest scoring LOIs are invited to submit full applications. Full applications are reviewed by members of amfAR’s scientific advisory committee and discussed during an in-person meeting to assess the merit of each application with respect to:
- Expected impact on HIV cure clinical research
- Innovation and novelty in the proposed work
- Competency and track record of members of the team
- Possible scientific or budgetary overlap
- Successful applications, chosen based on review scores, comments and amfAR priorities are recommended to amfAR’s Board of Trustees for approval.
- The board of trustees has sole authority to approve grant funding.
- Grant agreements must be fully executed within 60 days following the notice of grant award.
- Documentation of all necessary institutional (e.g., IRB, IBC) and regulatory (e.g., FDA or foreign equivalent) approvals must be submitted within three months following the notice of grant award.